Trial Profile
A phase I/II trial of OM-MUC1 vaccine in Melbourne Breast cancer patients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 23 Nov 2015
Price :
$35
*
At a glance
- Drugs OM-MUC 1 (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 23 Nov 2015 New trial record